Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT00758602
Eligibility Criteria:
Inclusion Criteria:
* adult patients, \<=75 years of age;
* single organ recipients of renal allograft;
* negative pregnancy test for women of childbearing potential; reliable contraception must be used before starting drug therapy, until 6 weeks after the last dose of study medication.
Exclusion Criteria:
* severe gastrointestinal disease which may influence the absorption of oral drug therapy;
* severe infection, HIV or active hepatitis;
* active gastric ulcers;
* malignancy other than cured skin cancer;
* severe anemia, leucopenia or thrombocytopenia.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
75 Years
Study:
NCT00758602
Study Brief:
Protocol Section:
NCT00758602